home · filing · 0001376474-24-000235
8-K filed May 13, 2024, 7:59 PM ET
ticker NVEC
CIK 0000724910
leadership
confidence high
sentiment neutral
materiality 0.35
NVE director Richard Kramp dies; Dr. Kelly Wei elected to board
NVE CORP /NEW/
Director Richard W. Kramp passed away May 2, 2024 after an illness; served on NVE board since 2014.
Dr. Kelly Wei elected to board effective May 13, 2024 to fill unexpired term ending at 2024 annual meeting.
Wei is VP of Corporate Strategy at Medtronic, appointed to Compensation and Nominating committees.
Board determined Wei is independent under NASDAQ Listing Rule 5605(a)(2) and SEC regulations.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Kelly Wei
Director
Effective 2024-05-13
Filed May 13, 2024, 7:59 PM ET
the NVE Board of Directors elected Kelly Wei, Ph.D. to join the Board effective May 13, 2024.
Departed
Richard W. Kramp
Director
Effective 2024-05-02
Successor Kelly Wei
Filed May 13, 2024, 7:59 PM ET
Director Richard W. Kramp passed away on May 2, 2024.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kelly Wei was elected as Director at NVE CORP /NEW/.
Action elected
Role Director
Exact text from the filing
the NVE Board of Directors elected Kelly Wei, Ph.D. to join the Board effective May 13, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard W. Kramp departed as Director at NVE CORP /NEW/.
Action passed away
Role Director
Exact text from the filing
Director Richard W. Kramp passed away on May 2, 2024.
View on SEC.gov
Source: SEC EDGAR
accession 0001376474-24-000235
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.